TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $896,348 | +4.0% | 57,941 | +5.6% | 0.00% | 0.0% |
| Q2 2023 | $861,726 | -2.4% | 54,852 | +2.4% | 0.00% | 0.0% |
| Q1 2023 | $882,783 | +10.7% | 53,567 | +4.8% | 0.00% | 0.0% |
| Q4 2022 | $797,644 | +18.3% | 51,131 | -1.7% | 0.00% | – |
| Q3 2022 | $674,000 | -9.3% | 52,022 | -1.7% | 0.00% | -100.0% |
| Q2 2022 | $743,000 | -21.8% | 52,905 | -20.2% | 0.00% | 0.0% |
| Q1 2022 | $950,000 | -99.1% | 66,334 | -99.2% | 0.00% | -98.3% |
| Q4 2021 | $111,631,000 | +108.4% | 8,190,093 | +150.5% | 0.06% | +87.5% |
| Q3 2021 | $53,558,000 | +176.8% | 3,269,718 | +184.4% | 0.03% | +166.7% |
| Q2 2021 | $19,347,000 | +61.6% | 1,149,564 | +75.3% | 0.01% | +50.0% |
| Q1 2021 | $11,971,000 | -55.4% | 655,623 | -55.5% | 0.01% | -50.0% |
| Q4 2020 | $26,840,000 | -39.3% | 1,474,733 | -40.5% | 0.02% | -46.7% |
| Q3 2020 | $44,192,000 | +4.8% | 2,477,086 | +5.3% | 0.03% | -9.1% |
| Q2 2020 | $42,161,000 | +21.9% | 2,351,403 | +3.2% | 0.03% | +6.5% |
| Q1 2020 | $34,579,000 | -0.1% | 2,277,961 | +29.9% | 0.03% | +24.0% |
| Q4 2019 | $34,599,000 | +24.6% | 1,753,618 | +8.6% | 0.02% | +13.6% |
| Q3 2019 | $27,779,000 | -13.4% | 1,615,018 | -10.9% | 0.02% | -12.0% |
| Q2 2019 | $32,094,000 | -17.5% | 1,813,248 | -5.0% | 0.02% | -34.2% |
| Q1 2019 | $38,896,000 | -65.6% | 1,909,450 | -70.8% | 0.04% | -66.7% |
| Q4 2018 | $113,024,000 | – | 6,548,306 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |